Prescribing Practice of Third Generation Cephalosporins in Medical Wards at Hospital Queen Elizabeth II (HQEII)

Authors

  • Nur Fairuz Sabrina Hashim Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia
  • Qishtina Mizan 1 Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia
  • Hong Tshun Kuan Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia
  • Dina Cyla Danny Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia
  • Lai Shuhua Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia
  • Goh Qing Liang Department of Pharmacy, Hospital Queen Elizabeth II, Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.51200/bjms.v15i3.2631

Keywords:

prescribing appropriateness, ceftazidime , melioidosis , third-generation cephalosporin

Abstract

Cephalosporins are amongst the most used antibiotics in hospital settings worldwide. The antibiotic report collated by the Pharmacy Department from Hospital Queen Elizabeth II
(HQEII) in 2018 reflected high usage of third generation cephalosporins in medical wards, and indeed HQE II was one of the top users nationwide. This study aimed to evaluate the prescribing pattern of third-generation cephalosporins in medical wards as per National Antimicrobial Guidelines (NAG) 2019. A prospective, observational study was conducted in medical wards from June 2019 till January 2020. Patients who were started with third-generation cephalosporins (ceftazidime, ceftriaxone, cefotaxime, cefoperazone/sulbactam)
were recruited, where 137 patients were enrolled with 60.6% were males. The mean age of patients was 53+16.8 years old. Antibiotics were initiated as per NAG recommendation. Cultures were taken before antibiotic initiation. Respiratory-related infections (n = 54, 39.4%) were the main indication and, antibiotics were continued as definite therapy in 38 patients (27.7%). The median duration of antibiotic treatment was 5 days (interquartile range = 3). Ceftazidime (n = 85, 62%) was most prescribed followed by ceftriaxone (n = 48, 35%)
and cefotaxime (n = 4, 2.9%) respectively. It was worth noting that ceftazidime was primarily
used as empirical therapy for melioidosis (n = 64, 75.3%), particularly in patients with diabetes mellitus (n = 40, 62.5%), chronic kidney disease (n = 27, 42.2%), and/or occupational exposure (n = 4, 6.3%). The mean ceftazidime duration for empirical melioidosis was 3.2+1.6 days. Overall, third-generation cephalosporins were appropriately prescribed in medical wards as per NAG 2019. Further exploration of ceftazidime usage in empirical melioidosis is warranted.

 

Published

2021-09-30

How to Cite

Nur Fairuz Sabrina Hashim, Mizan, Q., Hong Tshun Kuan, Dina Cyla Danny, Lai Shuhua, & Goh Qing Liang. (2021). Prescribing Practice of Third Generation Cephalosporins in Medical Wards at Hospital Queen Elizabeth II (HQEII). Borneo Journal of Medical Sciences (BJMS), 15(3), 25–36. https://doi.org/10.51200/bjms.v15i3.2631
Total Views: 264 | Total Downloads: 286